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http://www.cardiothoracicsurgery.org/content/9/1/137RESEARCH ARTICLE Open AccessPreoperative anemia increases mortality and
postoperative morbidity after cardiac surgery
Antonio Miceli1,2, Francesco Romeo3, Mattia Glauber2, Paolo M de Siena1, Massimo Caputo1,4 and Gianni D Angelini1*Abstract
Background: Anemia is an established adverse risk factor in cardiovascular disease. However, the effect of
preoperative anemia is not well defined in heart surgery. This study evaluates the effect of preoperative anemia on
early clinical outcomes in patients undergoing cardiac surgery.
Methods: A retrospective, observational, cohort study of prospectively collected data was undertaken on 7,738
consecutive patients undergoing heart surgery between April 2003 and February 2009. Of these, 1,856 patients with
preoperative anemia were compared to 5,882 patients without anemia (control group). According to the World
Health Organization, anemia was defined as hemoglobin level < 13 g/dl for men and <12 g/dl for women.
Selection bias not controlled by multivariable methods was assessed with propensity-adjustment method.
Results: Overall mortality was 2.1%. Preoperative anemia was associated with tripling in the risk of death (4.6% vs
1.5%, p < 0.0001) and postoperative renal dysfunction (18.5% vs 6.5%, p < 0.0001). There was also a significant
difference between the anemic and non-anemic group in the risk of postoperative stroke (1.9% vs 1.1%, p = 0.008),
atrial fibrillation (36.7% vs 33%, p = 0.003) and length of hospital stay > 7 days (54% vs 36.7%, p < 0.0001). In
propensity-adjusted, multivariable logistic regression, preoperative anemia was an independent predictor of mortality
(odds ratio [OR] 1.44, 95% confidence interval [CI] 1.02 to 2.03), postoperative renal dysfunction (OR 1.73, 95% CI 1.43 to
2.1) and length of hospital stay > 7 days (OR 1.3, 95% CI 1.15 to 1.47).
Conclusion: In patients undergoing heart surgery, preoperative anemia is associated with an increased risk of mortality
and postoperative morbidity.
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Anemia is an established adverse risk factor for cardio-
vascular disease [1]. Several studies have shown that low
levels of hemoglobin are associated with increased mor-
tality and morbidity in elderly population, in patients
with congestive heart failure and coronary artery disease,
especially in the setting of acute coronary syndrome
[2-6]. However, the effect of preoperative anemia in car-
diac surgery remains controversial. Previous investiga-
tions found preoperative anemia to be an independent
risk factor of in-hospital mortality and morbidity after
coronary artery bypass grafting (CABG) or valve surgery
[7-12]. However, others failed to demonstrate significant
differences in adverse outcomes between patients with* Correspondence: G.D.Angelini@bristol.ac.uk
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unless otherwise stated.low and normal hemoglobin levels [13,14]. Furthermore,
Kulier et al. demonstrated that the presence of anemia
in patients undergoing CABG was only an independent
predictor of non cardiac events, whereas adverse cardiac
outcomes, such as death from cardiac causes, myocardial
infarction and heart failure were more related to con-
comitant patients’ co- morbidities rather than anemia
per se [15]. Finally, the most commonly used preopera-
tive risk stratification models in cardiac surgery, such as
EuroSCORE, STS risk and ACEF, do not consider pre-
operative anemia a potential predictor of adverse out-
come and only 2 out of 19 risk stratification models
recognize anemia as an independent predictor of mortal-
ity [11,16,17]. Therefore, the aim of the present study
was to evaluate the effect of preoperative anemia on
early clinical outcomes in patients undergoing cardiac
surgery.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Patients and data collection
This was a retrospective, observational, cohort study of
prospectively collected data from consecutive adult pa-
tients who underwent cardiac surgery at the Bristol
Heart Institute between April 2003 and February 2009.
The study was approved by the clinical audit committee
of the University Hospital Bristol NHS Foundation Trust
and individual consent was waived. The data collection
form is entered in a database patient analysis and track-
ing system (Dendrite System, London, UK), and includes
five section that are filled in consecutively by anaesthe-
tists, cardiac surgeons, intensive care unit, and high
dependency unit and ward nurses. The base sample con-
tained detailed clinical information on approximately
8,196 patients. Exclusion criteria were patients who had
unknown preoperative hemoglobin levels and those with
pre-operative critical state, defined as any one or more
of the following: ventricular tachycardia or fibrillation or
aborted sudden death, preoperative cardiac massage,
preoperative ventilation before arrival in the anesthetic
room, preoperative inotropic support, intra-aortic bal-
loon counterpulsation or preoperative acute renal failure
(anuria or oliguria < 10 ml/hour) or emergency opera-
tions. The final sample size was 7,738 patients, of which
1,856 (24%) had preoperative anemia (Figure 1).End points and definitions
The primary end point was mortality, defined as any
death occurring within 30 days of operation. Secondary
end points were as follows: post-operative renal dysfunc-
tion (PRD), atrial fibrillation (AF), myocardial infarction
(MI), stroke, and length of hospital stay.
According to the World Health Organization, anemia was
defined as hemoglobin level < 13 g/dl for men and <12 g/dlFigure 1 Study profile.for women. Priority of surgery was defined as follow: urgent
(medical factors requiring the patient to stay in hospital
waiting for an operation), or elective (the clinical status of
the patient allows discharge from hospital with readmission
for surgery at a later date). A diagnosis of post-operative MI
was based on the presence of new Q waves >0.04 ms and/or
a reduction in R waves >25% in at least 2 contiguous
leads on electrocardiogram. The PRD was defined as
a serum creatinine level >200 mol/l after surgery.
New onset of postoperative AF was defined as any
duration at any time in the post- operative period on
the basis of a rhythm strip or 12-lead ECG. A diagno-
sis of stroke was made if there was evidence of new
neurological deficit with morphological substrate con-
firmed by computed tomography or nuclear magnetic res-
onance imaging.Anaesthetic, surgical technique and postoperative
management
Anaesthetic and surgical techniques were standardized
for all patients and were reported previously [18]. In
brief, all operations requiring cardiopulmonary bypass
were conducted using a membrane oxygenator, primed
with 1000 ml of Hartmanns crystalloid, 500 ml Gelofu-
sine, 0.5 g/kg mannitol, 7 ml of 10% calcium gluconate,
and 6000 IU heparin. α-Stat pH management was used,
and the systemic temperature was kept between 34°C and
36°C. Myocardial protection was achieved with intermit-
tent hyperkalaemic warm blood cardioplegia for CABG
and hyperkalaemic cold blood cardioplegia for all other
operations. For off-pump CABG, the Bristol technique was
used to expose the coronaries and provide stabilization to
undertake anastomosis [19]. At the end of surgery, patients
were transferred to the intensive care unit and managed
according to the unit protocol.
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Continuous data were expressed as mean ± standard de-
viation, and categorical data as percentages. The Kolmo-
gorov–Smirnov test was used to check for normality of
data in the two groups before further analysis. Differ-
ences between anemia and control group were com-
pared using χ2 test for categorical variables, and the
Student t test or the Wilcoxon rank sum test, as appro-
priate, for continuous variables. To reduce the effect of
selection bias and potential confounding in this observa-
tional study, a propensity score was undertaken. The
propensity for anemia was determined without regard of
outcomes by the use of a nonparsimonious multiple
logistic-regression analysis. All the variables listed in
Table 1 were included in the analysis. Logistic regression
was performed to assess the effect associated with
anemia on each end point after adjusting for potentially
confounding variables listed in Table 1 and the propensity
score. Results are reported as percentages and odds ratios







Age (years ± SD) 69 ± 10.6 64.5 ± 11.6 <0.0001
Hemoglobin level (g/dl ± SD) 11.5 ± 1.1 14.3 ± 1.1 <0.0001
Female, n (%) 517 (27.9) 1419 (24.1) <0.001
NYHA III-IV class, n (%) 809 (43.6) 1826 (31) <0.0001
Diabetes, n (%) 424 (22.8) 703 (12) <0.0001
Diabetes, n (%) 424 (22.8) 703 (12) <0.0001
Hypertension, n (%) 1306 (70.4) 3910 (66.5) 0.002
Chronic Pulmonary disease,
n (%)
293 (15.8) 661 (11.2) <0.0001
Renal failure, n (%) 85 (4.6) 42 (0.7) <0.0001
Extracardiac arteriophaty,
n (%)
222 (12) 429 (7.3) <0.0001
Previous cardiac operations,
n (%)
128 (6.9) 330 (5.6) 0.046
Preoperative EF (%), n (%) <0.0001
Good 1296 (69.8) 4579 (77.8)
Fair 439 (23.7) 1114 (18.9)
Poor 121 (6.5) 189 (3.2)
Recent MI, n (%) 479 (25.8) 987 (16.8) <0.0001
Emergency, n (%) 78 (4.2) 90 (1.5) <0.0001
Cardiac procedures <0.0001
CABG, n (%) 1075 (57.9) 3775 (64.2)
Single valve surgery (n, %) 319 (17.2) 935 (15.9)
Combined procedures (n, %) 372 (20) 655 (11.1)
Aortic surgery, n (%) 90 (4.8) 217 (3.7)
NYHA: New York Heart Association, EF: Ejection fraction; MI: myocardial
infarction; CABG: coronary artery bypass grafting.P values are two-sided, and P values of less than .05 were
considered to indicate statistical significance. All statis-
tical analysis was performed with SPSS 15.0 (SPSS Inc,
Chicago, Ill).
Results
In the study population of 7,738 patients undergoing
cardiac surgery, a total of 1,856 (24%) patients had pre-
operative anemia (Figure 2), of which 517 (27.9%) were
female. The mean (±standard deviation, SD) hemoglobin
concentration was 11.5 (SD, 1.1) g/dl versus 14.3 (SD,
1.1) g/dl, in the anemic and control patients group, re-
spectively. Baseline characteristics of the study popula-
tion are shown in Table 1. Patients in the anemia group
were older and more often female; they were more likely
to have a greater prevalence of hypertension, chronic ob-
structive pulmonary disease, chronic kidney disease,
extracardiac arteriophaty, and previous cardiac opera-
tions. Patients with anemia were also more likely to have
a lower ejection fraction and greater prevalence of New
York Heart Association functional class. Finally, the
prevalence of patients undergoing other than isolated
CABG and aortic surgery were higher in the anemic pa-
tients than in the control group. The overall rate of mor-
tality was 2.1%. Results from univariate and multivariable
logistic analysis are reported in Tables 2 and 3. Preopera-
tive anemia was associated with a three-fold increased in
the risk of death (4.6% vs 1.5%, p < 0.0001) and postopera-
tive renal dysfunction (18.5% vs 6.5%, p < 0.0001). There
was also a significant difference between the anemic and
non-anemic group in the risk of postoperative stroke
(1.9% vs 1.1%, p = 0.008), atrial fibrillation (36.7% vs 33%,
p = 0.003) and length of hospital stay > 7 days (54% vs
36.7%, p < 0.0001. There was no significant difference in
postoperative myocardial infarction (1.9% vs 2%, p = 0.93)
between the two groups. After adjusting for confounding
variables listed in Table 1, as well as propensity score, pre-
operative anemia was an independent predictor of mortal-
ity, postoperative renal dysfunction and length of hospital
stay > 7 days. Finally, when modeled as univariate continu-
ous variable, a curvilinear relationship was seen between
the estimated probability of death and preoperative
hemoglobin either in the female or in the male population
(Figure 3).
Discussion
Our study demonstrates that preoperative anemia de-
fined by the World Health Organization as hemoglobin
level <13 g/dl for men and <12 gr/dl for women, is a risk
factor for mortality and morbidity in patients undergoing
cardiac surgery. Low levels of hemoglobin were associated
with tripling in the risk of death and postoperative renal
dysfunction. Furthermore, patients with preoperative
anemia had a 30% increased risk of prolonged hospital
Figure 2 Distribution of preoperative hemoglobin levels among patients in the study.
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ship between anemia and the risk of myocardial infarction.
Finally, as shown in Figure 3, the estimated probability of
death increased with decreasing levels of preoperative
hemoglobin.
Anemia is an established risk factor for cardiovascular
disease in the general population [1,2]. The authors of
the ARIC (Atherosclerosis Risk in Communities) study
analyzed 14,410 low risk subjects in the general popula-
tion between the ages of 45 and 64 years and suggested
that anemia was associated with increased risk in the
total rate of myocardial infarction, coronary angioplasty,






Mortality, % (n) 76 (4.6) 88 (1.5) <0.0001
Atrial fibrillation, % (n) 682 (36.7) 1942 (33) 0.003
Renal dysfunction, % (n) 344 (18.5) 384 (6.5%) <0.0001
Stroke, % (n) 36 (1.9) 65 (1.1) 0.008
Myocardial infarction, % (n) 36 (1.9) 118 (2) 0.93
Length of hospital
stay >7 days, % (n)
1002 (54) 2159 (36.7) <0.0001[1]. Moreover, several studies have shown that low levels
of hemoglobin were independent predictors of mortality
and morbidity in patients with heart failure and coronary
artery disease [3-6]. In a cohort of 12,065 patients with
new-onset heart failure, Ezekowitz showed a 34% in-
creased risk in mortality associated with anemia [3]. Fur-
thermore, Sabatine et al. in a review of 39,922 patients
from 16 randomized trials, demonstrated that patients
with ST- elevation MI had a progressive increase in car-
diovascular mortality and heart failure as the baseline
hemoglobin dropped below 14 g/dl, whereas subjectsTable 3 Observed and adjusted ORs of postoperative
adverse outcomes after cardiac surgery, according to the





Mortality 2.81 (2.06-3.84) 1.44 (1.02-2.03)
Atrial fibrillation 1.18 (1.06-1.31) 0.96 (0.85-1.08)
Renal dysfunction 3.26 (2.8-3.8) 1.73 (1.43-2.1)
Stroke 1.77 (1.17-2.67) 0.95 (0.61-1.47)
Myocardial infarction 0.967 (0.66-1.4) 0.79 (0.53- 1.19)
Length of hospital stay >7 days 2.03 (1.82–2.25) 1.3 (1.15–1.47)
*Adjusted for baseline characteristics and propensity score.
Figure 3 Probability of death according to preoperative hemoglobin levels.
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diovascular death, MI, and recurrent ischemia as the
baseline hemoglobin fell below 11 g/dl [5].
Anemia is the most common hematological problem
in the preoperative patient and according to the defin-
ition used, its incidence ranges from 22% to 30% and
over 40% in octogenarians [8-14]. In our sample, one
quarter of patients undergoing surgery were anemic. A
number of studies have shown a significant association
between anemia and adverse outcomes after surgery
[20-22]. Wu et al. analyzed the effect of preoperative
hematocrit levels in over 310,000 elderly veterans under-
going non-cardiac surgery and found that even mild
anemia was associated with an increased risk of 30-day
mortality and morbidity [20]. In addition, they showed a
linear rise in death and cardiac events when the
hematocrit level was less than 39% [20]. Similar results
are reported in patients undergoing cardiac surgery
[7-13]. In a large multicenter cohort study on 3,500 pa-
tients, Karkuti et al. found that preoperative anemia was
independently associated with doubling in the composite
risk of in-hospital death, stroke, or acute kidney injury;
the same odds were even obtained after adjusting for
confounders by propensity score matching [8]. Using the
same statistical technique, Ranucci et al. demonstrated
that patients with any degree of anemia had a signifi-
cantly higher rate of stroke, major morbidity and higher
operative mortality rate [12]. Zindrou et al. observed
that individuals with a preoperative hemoglobin concen-
tration of 10 g/dl or less had a 3-fold increase in the
odds of in-hospital mortality after CABG than those
with a higher hemoglobin concentration [7]. Finally, inthe setting of cardiac valve surgery, Clandellas et al. found
that patients with preoperative hemoglobin <12 mg/dl had
a 3-fold increased risk of death and 5-fold in the odds of
developing major postoperative complications such as,
heart failure, myocardial infarction, reoperation for bleed-
ing, neurological complication and acute renal failure [10].
Nevertheless, other studies failed to show a negative im-
pact of preoperative anemia on adverse postoperative out-
comes. Bell et al. and Carrascal et al. demonstrated that
low preoperative hemoglobin level was not an independ-
ent risk factor for early mortality after CABG and that it
was only mildly significant for morbidity even in octogen-
arian patients [13,14]. In addition, Kulier et al. demon-
strated that the presence of low hemoglobin levels did not
predict postoperative cardiac outcomes, such as myocar-
dial infarction, congestive heart failure or death from
cardiac causes, but only renal and cerebral adverse com-
plications [15]. The different results reached by these au-
thors might be partially explained by the threshold chosen
for the definition of preoperative anemia. These studies
used cutoff points for preoperative hemoglobin that
ranged from 10 to 12.5 g/dl and, most of them focused
only on single isolated procedures. On the contrary, the
strength of our investigation was to define anemia accord-
ing to the World Health Organization and evaluate
prospectively collected data from a large number of con-
secutive patients undergoing different cardiac surgery
operations.
Finally, the best known risk stratification tools do not
consider low hemoglobin level a potential predictor of
adverse outcome [16]. These controversies have raised
the question of whether preoperative anemia is a marker
Miceli et al. Journal of Cardiothoracic Surgery 2014, 9:137 Page 6 of 7
http://www.cardiothoracicsurgery.org/content/9/1/137of other concomitant comorbidities such as advanced
age, diabetes and renal dysfunction, or a risk factor “per
se”. According to Ranucci et al., anemia is often ex-
cluded from the risk model because of the low preva-
lence of anemic patients in the examined populations
and the strong correlation (multicollineratity) between
low hemoglobin levels and other comorbidities [12]. In
our sample, one quarter of patients were anemic and we
demonstrated that anemia was still an independent pre-
dictor of mortality and morbidity after adjusting for
baseline characteristics and propensity score.
The association between preoperative anemia and ad-
verse outcomes in patients after cardiac surgery may
have several explanations. First, anemic patients are at
risk for inadequate tissue oxygenation delivery during
the peri-operative period, which may lead to impaired
tissue oxygenation and organ dysfunction. Second,
anemia is the most important predictor of hemodilution
during cardiopulmonary bypass. It has been shown that
low hematocrit levels are independently associated with
mortality, stroke and acute renal failure [12,23-25].
Finally, anemia is the strongest predictor of blood
transfusions [21,26]. It has been shown that blood cell
transfusions in patients having cardiac surgery are
strongly associated with increased mortality and morbid-
ity [27]. These results might be related to the functional
and structural changes that occur in stored blood cells.
The increased red cell aggregability and rigidity, the ac-
cumulation of potentially toxic microparticles or proin-
flammatory cytokines as well as the depletion of NO in
the stored blood might promote vasoconstriction, plate-
let aggregation and ineffective oxygen depletion, causing
tissue hypoxia and organ dysfunction [27-29].
Despite of low levels of hemoglobin have been associ-
ated with worse results, preoperative anemia is a risk
factor that can be modified by treatment before surgery.
In this regard, the updated guidelines of the Society of
Thoracic Surgeons and the Society of Cardiovascular
Anesthesiologists Blood Conservation recommend the
preoperative administration of erythropoietin and iron
therapy with the aim of increasing hemoglobin levels
(class II a, level of evidence B) [30]. Finally, it has been
proposed that prophylactic blood transfusions might
limit any subsequent deleterious effects by stabilizing
the iron metabolism and production of oxidative reac-
tion before surgery come into play [31]. However, more
studies are required to confirm these data.
Study limitation
This study is based on the retrospective analysis of our
large institutional observational prospectively collected
database, and we are unable to account for the influence
of any residual unmeasured factors that could affect the
adverse outcomes. Furthermore, we did not take intoaccount specific details on the intraoperative and post-
operative management of these patients and in particular
information regarding the minimum Ht level during car-
diopulmonary bypass, postoperative blood loss and
blood transfusions.
Conclusions
In patients undergoing cardiac surgery, preoperative
anemia, defined as hemoglobin level < 13 g/dl for men
and <12 g/dl for women, is an independent risk factor
for mortality, postoperative renal dysfunction, stroke and
prolonged hospital stay.
Abbreviation
CABG: Coronary artery bypass grafting; PRD: Post-operative renal dysfunction;
AF: Atrial fibrillation; MI: Myocardial infarction; OR: Odds ratio; CI: Confidence
interval; SD: Standard deviation.
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